General Information of the Compound
Compound ID |
CP0344949
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(2R)-N-hydroxy-2-[(4-methoxybenzene)(pyridin-3-ylmethyl)sulfonamido]-3-methylbutanamide
Show/Hide
|
||||||||||||||||||
Synonyms |
(2R)-N-hydroxy-2-[(4-methoxyphenyl)sulfonyl-(pyridin-3-ylmethyl)amino]-3-methylbutanamide
161314-70-1
1bm6
1eub
2w0d
3MP-HAV-MSB
80AXY59IT2
AC1L9JQY
BDBM50066658
BDBM8465
BMCL16311 Compound 1a
BSIZUMJRKYHEBR-QGZVFWFLSA-N
CGS
CGS 27023
CGS-27023
CGS-27023A
CGS-27023A free base
CHEMBL267178
CHEMBL514138
DB07556
GTPL8846
MMI-270B free base
MMI270
MMI270B free base
N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE
SCHEMBL3468445
UNII-80AXY59IT2
hydroxamate analogue 1
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C18H23N3O5S
|
||||||||||||||||||
Molecular Weight |
393.465
|
||||||||||||||||||
Canonical SMILES |
COc1ccc(cc1)S(=O)(=O)N(Cc1cccnc1)[C@H](C(C)C)C(=O)NO
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C18H23N3O5S/c1-13(2)17(18(22)20-23)21(12-14-5-4-10-19-11-14)27(24,25)16-8-6-15(26-3)7-9-16/h4-11,13,17,23H,12H2,1-3H3,(H,20,22)/t17-/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
BSIZUMJRKYHEBR-QGZVFWFLSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( MMI270 )
Drug Name | MMI270 | ||
---|---|---|---|
Target(s) |